Ophthalmology Times
246 FOLLOWERS
Ophthalmology Times is a physician-driven publication that disseminates news and information of a clinical, socioeconomic, and political nature in a timely and accurate manner for members of the ophthalmic community. Get into their blog and learn more about the latest news, resources, articles, interviews, case studies, podcasts, conferences, and more.
Ophthalmology Times
9h ago
Eleonora Lad, MD, PhD, spoke about her presentation, "Multiwavelength photobiomodulation significantly reduces risk for vision loss and onset of geographic atrophy in dry age-related macular degeneration" at this year's American Society of Retina Specialists (ASRS) meeting in Stockholm, Sweden ..read more
Ophthalmology Times
9h ago
Stephen Russell, MD, discussed his presentation on safety and durability of voretigene neparvovec-rzyl for biallelic RPE65 at the annual ASRS meeting in Stockholm, Sweden ..read more
Ophthalmology Times
11h ago
Nathan Steinle, MD, spoke about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden ..read more
Ophthalmology Times
15h ago
Researchers note work may lead to targets for conventional outflow pathway therapies ..read more
Ophthalmology Times
15h ago
Alan Franklin, MD, PhD, FASRS, spoke about his presentation, "Intraoperative Fluorescein Angiography Reduces the Rate of Postoperative Vitreous Hemorrhage" at this year's American Society of Retina Specialists (ASRS) meeting in Stockholm, Sweden ..read more
Ophthalmology Times
15h ago
AG-73305 is bi-specific, with anti-VEGF and anti-integrin. The dual mechanism of action has provided some interesting results ..read more
Ophthalmology Times
2d ago
Ashkan Abbey, MD, spoke about his presentation on the CALM registry study, the 36-month outcomes of real-world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden ..read more
Ophthalmology Times
2d ago
According to the company, the Denali trial is evaluating NCX 470 safety and efficacy in patients with open-angle glaucoma or ocular hypertension and topline results continue to be expected in H2 2025 ..read more
Ophthalmology Times
2d ago
According to the company, OCU410 utilizes an adeno-associated virus platform for the retinal delivery of the RORA gene ..read more